Devon Jeffcoat, MD
Orthopaedic Trauma · Los Angeles, CANPI 1932318748
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Synthes GmbH accounts for 61.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $17,873 and has fallen 79.6% since, to $3,648 in 2025.
Across 32 payments — averaging $944.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$19K
- Globus Medical$6K
- Medical Device Business Services, Inc.$5K
- Zimmer Biomet$193
- Johnson & Johnson$116
- Biocomposites Inc$96
What the payments were for
- Consulting fees$7,65025%
- Speaking & faculty fees$16,45054%
- Travel & lodging$4,74116%
- Food & beverage$1,3955%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 20 | $18,580 |
| Globus Medical | 3 | $6,030 |
| Medical Device Business Services, Inc. | 4 | $5,220 |
| Zimmer Biomet | 1 | $193 |
| Johnson & Johnson | 3 | $116 |
| Biocomposites Inc | 1 | $96 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clavicle Fixation$5,950
- VA-LCP PLATES & SCREWS$5,150
How this compares
$30,235 in reported general payments places this provider in the 70th percentile of 106 orthopaedic trauma providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 11 | $69 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in Los Angeles
- Christopher LeeLos Angeles$475K
- Joshua GaryLos Angeles$466K
- Joseph PattersonLos Angeles$69K
- Eric JohnsonLos Angeles$36K
- Sarah BlumenthalLos Angeles$29K
- Mark FlemingLos Angeles$18K
- Michael GardnerStanford$2.9M
- Aaron OsborneRedding$1.3M
- Robert Tonksla Jolla$1.3M
- John ScolaroOrange$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.